ArticleBMC cardiovascular disorders2021

Renoprotective effects of sodium glucose cotransporter 2 inhibitors in type 2 diabetes patients with decompensated heart failure.

Masaki Nakagaito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.